Holding(s) in Company

Allergy Therapeutics PLC 09 November 2007 TR-1: notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing Allergy Therapeutics plc shares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other: Transferred to external fund manager X 3. Full name of person(s) subject to the notification obligation: BT Pension Scheme Trustees Limited as trustess of the BT Pension Scheme 4. Full name of shareholder(s) (if different from 3.): N/A 5. Date of the transaction and date on which the threshold is 1 November 2007 crossed or reached: 6. Date on which issuer notified: 8 November 2007 7. Threshold that is reached or crossed: 3% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous Resulting situation after the triggering transaction to the Triggering if possible using the transaction ISIN CODE Number of Number of Number of Number of voting rights % of voting rights Shares Voting shares Rights Direct Direct Indirect Direct Indirect GB00B02LCQ05 4,540,027 2,511,761 2,511,761 0 3.06% 0.00% ORD £0.001 B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting instrument Period/ Date that may be acquired if rights the instrument is exercised/ converted N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 2,511,761 3.06% 9 Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Proxy Voting: 10 Name of the proxy holder: See 13 below 11 Number of voting rights proxy holder will cease to hold: See 13 below 12 Date on which proxy holder will cease to hold voting rights: See 13 below 13 Additional information: Hermes Investment Management Limited hold the voting rights under a standing proxy contained in investment management agreements with various underlying clients, which includes all of the shares owned directly by the BT Pension Scheme. All voting rights held on behalf of the above entities are aggregated for the purposes of DTR 5.2.1(a) and disclosed pursuant to DTR 5.1.5. This disclosure is made by BT Pension Shceme Trustees Limited, which is the ultimate parent undertaking for the purposes of DTR 5.2.1(e). This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings